Fed. Circ. Tosses ‘Unusual’ Appeal On Menopause Drug IP – Law360

Fed. Circ. Tosses ‘Unusual’ Appeal On Menopause Drug IP – Law360

Law360 (April 20, 2021, 10:59 PM EDT) — The Federal Circuit on Tuesday dismissed an “unusual” appeal from drugmaker Sebela Ireland Ltd., which sought affirmation of a district court decision that claims in two patents covering its menopause drug are obvious, while at the same time asking the appellate court not to weigh in on written description and utility issues.

The three-judge panel said in its nonprecedential decision that, while a New Jersey federal judge briefly addressed written description and utility, she didn’t do so conclusively. Since Sebela isn’t trying to overturn the obviousness ruling, and there are no alternative holdings to the district court’s obviousness decision, the panel…

This content was originally published here.

Melissa Carroll
Melissa Carroll

Over the past 25 years, I’ve cultivated my professional skills in healthcare sales and marketing to help healthcare practices provide better care and a more satisfying experience overall. I am a lifelong student of wellness, nutrition and alternative therapies. When I’m not helping providers, you can find me with my children or at our gym helping members reach their wellness goals. My passion is helping people achieve more in their lives. Whether personal or professional, it all comes together for happier living.

Recommended For You

Subscribe to Our Newsletter for Valuable Information and Savings

Newsletter